Literature DB >> 1453531

New challenges in the development of a conjugate pneumococcal vaccine.

R S Baltimore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1453531

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Predicting cost-benefits before programs are started: looking at conjugate vaccine for invasive pneumococcal infections.

Authors:  W J Hueston; A G Mainous; N Brauer
Journal:  J Community Health       Date:  2000-02

2.  Serotypes of Streptococcus pneumoniae causing invasive childhood infections in Bangladesh, 1992 to 1995.

Authors:  S K Saha; N Rikitomi; D Biswas; K Watanabe; M Ruhulamin; K Ahmed; M Hanif; K Matsumoto; R B Sack; T Nagatake
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Serotyping of Streptococcus pneumoniae by agglutination assays: a cost-effective technique for developing countries.

Authors:  M K Lalitha; R Pai; T J John; K Thomas; M V Jesudason; K N Brahmadathan; G Sridharan; M C Steinhoff
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

4.  Distribution of serotypes of Streptococcus pneumoniae isolated from invasive infections over a 16-year period in the greater São Paulo area, Brazil.

Authors:  M C Brandileone; V S Vieira; R C Zanella; I M Landgraf; C E Melles; A Taunay; J C de Moraes; R Austrian
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

5.  Pneumococcal Vaccination in Adults.

Authors:  Tsering Y Sherpa; Howard L Leaf
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

6.  The changing epidemiology of invasive bacterial infections in Massachusetts children, 1984 through 1991.

Authors:  A M Loughlin; C D Marchant; S M Lett
Journal:  Am J Public Health       Date:  1995-03       Impact factor: 9.308

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.